Recent Advances in Ovarian Cancer

The program will examine hereditary ovarian cancer including how genetic testing is being utilized to identify high-risk women and to tailor therapy for women with ovarian cancer, new surgical and chemotherapeutic options for the initial management of ovarian cancer, and novel therapeutic approaches for women with recurrent ovarian cancer. The target audience includes oncologists, obstetricians/gynecologists, and primary care providers.

Wednesday, September 30 at 5:00pm to 6:30pm


Google Calendar iCal Outlook

Recent Activity